# FDA Inspection 1113150 - Vitalant - November 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/vitalant/b064036b-0582-45f6-8ea1-d0ca9b90ecfe
Source feed: FDA_Inspections

> FDA Inspection 1113150 for Vitalant on November 20, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1113150
- Company Name: Vitalant
- Inspection Date: 2019-11-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1258490 - 2024-12-13](https://www.keypedia.com/records/fda_inspections/vitalant/c79f63ae-cd1d-4156-b6cf-4c4a5a20fc01)
- [FDA Inspection 1258490 - 2024-12-13](https://www.keypedia.com/records/fda_inspections/vitalant/20d4dc22-9385-4754-8dcb-cae44cb83a2e)
- [FDA Inspection 1063664 - 2018-07-27](https://www.keypedia.com/records/fda_inspections/vitalant/2c4b683d-40a4-4ad4-9612-75bd2578872c)
- [FDA Inspection 977715 - 2016-06-30](https://www.keypedia.com/records/fda_inspections/vitalant/4b3ef8c8-cba6-45b1-af0d-fba3ed2044eb)
- [FDA Inspection 878152 - 2014-05-06](https://www.keypedia.com/records/fda_inspections/vitalant/b292000e-1cdf-42f4-864e-9e7cc16f7409)

Company: https://www.keypedia.com/companies/vitalant/4ba6e656-d91b-4feb-ada0-283a53cc4392

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d